During the past decade, Centre Hospitalier de la Dracénie conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier de la Dracénie" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 3 trials, followed by "Groupe Oncologie Radiotherapie Tete et Cou" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 3 trials sponsored and "ARCAGY/ GINECO GROUP" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de la Dracénie" #1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 3 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "UNICANCER" with 2 trials as a collaborator, "AIO-Studien-gGmbH" with 1 trials as a collaborator and "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de la Dracénie" are "Breast Cancer" (4 trials), "Colorectal Cancer" (2 trials), "Pancreatic Cancer" (2 trials), "Squamous Cell Head and Neck Carcinoma" (2 trials) and "ALK Gene Mutation" (1 trials). Many other conditions were trialed in "Centre Hospitalier de la Dracénie" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de la Dracénie" are "Drug" (16 trials), "Other" (4 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Cisplatin" (3 trials), "Cetuximab" (2 trials), "Pemetrexed" (2 trials) and "fluorouracil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de la Dracénie" are 20 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospitalier de la Dracénie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Centre Hospitalier de la Dracénie, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de la Dracénie, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".